Susan Fox, PhD, ChB, MB BCh

Translational studies of new treatments for movement disorders, including phase II and phase IIII clinical studies.
Parkinsonism Relat Disord. 2019 Jan 10;:
Ruiz-Lopez M, Freitas ME, Oliveira LM, Munhoz RP, Fox SH, Rohani M, Rogaeva E, Lang AE, Fasano A
Mov Disord. 2019 Jan 17;:
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Lloret SP, Weintraub D, Sampaio C, and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based...
Mov Disord. 2018 Dec 21;:
Johnston TH, Geva M, Steiner L, Orbach A, Papapetropoulos S, Savola JM, Reynolds IJ, Ravenscroft P, Hill M, Fox SH, Brotchie JM, Laufer R, Hayden MR
J Neuroeng Rehabil. 2018 Nov 06;15(1):97
Li MH, Mestre TA, Fox SH, Taati B
Mov Disord Clin Pract. 2018 Jan-Feb;5(1):66-74
Udow SJ, Hobson DE, Kleiner G, Masellis M, Fox SH, Lang AE, Marras C
Ann Neurol. 2018 Oct 24;:
Espay AJ, Morgante F, Merola A, Fasano A, Marsili L, Fox SH, Bezard E, Picconi B, Calabresi P, Lang AE
Neuropharmacology. 2018 Jun 01;:
Johnston TH, Lacoste AMB, Visanji NP, Lang AE, Fox SH, Brotchie JM
Parkinsonism Relat Disord. 2018 May 05;:
Li MH, Mestre TA, Fox SH, Taati B

Pages